ELUTIA INC.

Develops drug-eluting biologics to reduce complications from medical implants.

ELUT | US

Overview

Corporate Details

ISIN(s):: US05479K1060
LEI:
Country:: United States of America
Address:: 12510 PROSPERITY DRIVE, 20904 SILVER SPRING
Website:: https://elutia.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Elutia Inc. is a commercial-stage company that develops and commercializes drug-eluting biologic products to improve compatibility between medical devices and patients. The company's proprietary drug-eluting biomaterial platforms combine natural biologic materials with extended-release antibiotics to address post-surgical complications from implant failures. Its key offerings include CanGaroo, an acellular device envelope for implantable electronics like pacemakers and neurostimulators, and SimpliDerm, a human acellular dermal matrix for soft tissue reconstruction. These products are designed to mitigate fibrotic responses, ensure implant stability, and support wound healing. Formerly known as Aziyo Biologics, the company rebranded to Elutia to reflect its strategic focus on drug-eluting biomatrices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ELUTIA INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELUTIA INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ELUTIA INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ObsEva SA Developed novel therapeutics for women's reproductive health and pregnancy.	Switzerland	OBSN
OCULAR THERAPEUTIX, INC Develops hydrogel drug delivery therapies for eye diseases like wet AMD and glaucoma.	United States of America	OCUL
Oculis Holding AG Clinical-stage biopharma developing non-invasive topical therapies for ophthalmic diseases.	United States of America	OCS
ODI Pharma AB Distributes pharmaceutical medicinal cannabis products across Eastern Europe, with a focus on Poland.	Sweden	ODI
Olema Pharmaceuticals, Inc. A clinical-stage biopharma developing targeted therapies for women's cancers, focusing on breast cancer.	United States of America	OLMA
OliX Pharmaceuticals, Inc. Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.	South Korea	226950
OMEROS CORP Develops first-in-class therapeutics for challenging diseases with unmet medical needs.	United States of America	OMER
ONCODESIGN Developing precision oncology solutions for resistant and metastatic cancers.	France	ALONC
Oncodesign Precision Medicine S.A Develops precision therapies & diagnostics for resistant and metastatic cancers.	France	ALOPM
Oncoinvent ASA Developing alpha-emitting radiotherapies for treating cancers in the peritoneal cavity.	Norway	OCIN